{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-046508","form_type":"8-K","ticker":"SSKN","cik":"0001051514","company_name":"STRATA Skin Sciences, Inc.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.507260+00:00","generated_at":"2026-05-30T00:45:59.526222+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"STRATA Skin Sciences Q3 rev $8.8M, first non-GAAP operating profit since 2018","bullets":["Revenue $8.8M (-1% YoY); recurring revenue $5.4M (+2% YoY); gross margin 60.3% (up from 56.0% YoY).","Non-GAAP operating profit $128K (excl. $1.8M NY tax accrual); first since 2018 refinancing.","Net loss narrowed to $0.3M ($0.08/sh) from $1.1M ($0.30/sh) in Q3 2023; cash $8.4M.","XTRAC domestic base 873 (down from 882 Q2); TheraClear X base 135 (up from 117 Q2).","Designated John Gillings (VP Finance) as principal financial & accounting officer; raised $2.1M in July equity offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-046508","json":"https://secwatch.observer/filing/0001140361-24-046508.json","markdown":"https://secwatch.observer/filing/0001140361-24-046508.md","text":"https://secwatch.observer/filing/0001140361-24-046508.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1051514/000114036124046508/0001140361-24-046508-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1051514/000114036124046508/ef20038566_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:45:59.526222+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b1c68e48ad","claim":"John Gillings was appointed as principal financial officer and principal accounting officer at STRATA Skin Sciences, Inc..","evidence_excerpt":"On November 13, 2024, Strata Skin Sciences, Inc. (the “Company”) designated its Vice President Finance, John Gillings, as its principal financial officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1051514/000114036124046508/0001140361-24-046508-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"designated"},{"label":"Role","value":"principal financial officer and principal accounting officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}